Blau Farmacêutica S.A. (BVMF:BLAU3)
Brazil · Delayed Price · Currency is BRL 9.56
-0.38 (-3.82%)
Jun 17, 2026, 5:03 PM GMT-3
Blau Farmacêutica Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Blau Farmacêutica stock has a consensus rating of "Hold" and an average price target of R$12.60. The average 1-year stock price forecast is 31.80% higher than the current stock price, while the lowest is R$9.00 (-5.86%) and the highest is R$17.00 (+77.82%).
Price Target: R$12.60 (+31.80%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Blau Farmacêutica stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 6 | 7 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 10 | 10 | 10 | 10 |
Financial Forecast
Revenue This Year
1.96B
from 1.70B
Increased by 15.29%
Revenue Next Year
2.22B
from 1.96B
Increased by 13.24%
EPS This Year
1.25
from 1.02
Increased by 23.33%
EPS Next Year
1.44
from 1.25
Increased by 15.05%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is BRL.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.0B | ||
| Avg | 2.0B | ||
| Low | 1.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.0% | ||
| Avg | 15.3% | ||
| Low | 11.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.47 | ||
| Avg | 1.25 | ||
| Low | 1.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 44.8% | ||
| Avg | 23.3% | ||
| Low | 13.2% |